Wells Fargo’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.6K Buy
16,118
+11,868
+279% +$40.3K ﹤0.01% 5719
2026
Q1
$17.8K Sell
4,250
-8,376
-66% -$34.9K ﹤0.01% 5818
2025
Q4
$54.4K Buy
12,626
+8,348
+195% +$31.8K ﹤0.01% 5561
2025
Q3
$18.6K Buy
4,278
+659
+18% +$2.97K ﹤0.01% 5811
2025
Q2
$16.8K Buy
+3,619
New +$14.3K ﹤0.01% 5830

Other funds holding SBC

Wells Fargo's SBC Position: Q2 2026 in Review

Wells Fargo increased its SBC Medical Group (SBC) stake by 279% in Q2 2026, buying an estimated $40.3K and bringing the position to 16,118 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5719.

Wells Fargo first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. The position peaked at $54.4K in Q4 2025. 56 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Wells Fargo held 16,118 shares of SBC Medical Group worth $49.6K as of Q2 2026.
  • Wells Fargo bought 11,868 SBC Medical Group shares in Q2 2026, an estimated $40.3K.
  • SBC Medical Group made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5719 holding.
  • Wells Fargo first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • Wells Fargo's SBC Medical Group position peaked at $54.4K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.